Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Rehabilitation With the Shoulder Pacemaker

NCT: NCT06501859 · ENROLLING_BY_INVITATION

NCT IDNCT06501859
StatusENROLLING_BY_INVITATION
Start Date2023-08-02
Completion2027-07
SponsorUniversity of Utah (OTHER)
First posted
Last updated

Brief Summary

The investigators purpose of the proposed study is to use the FDA approved Shoulder Pacemaker device in patients undergoing reverse shoulder arthroplasty and study the functional outcomes compared to a standard post-operative rehabilitation program. The investigators hypothesize that use of the Shoulder Pacemaker reduce pain and will allow for improved range of motion and function in patients undergoing RSA. The findings of this research may very well improve function in RSA patients through a novel, non-invasive approach.

Frequently Asked Questions

What is Rehabilitation With the Shoulder Pacemaker?

Rehabilitation With the Shoulder Pacemaker is a clinical trial registered under NCT06501859. Current status: ENROLLING_BY_INVITATION.

What is the status of NCT06501859?

The current status of NCT06501859 (Rehabilitation With the Shoulder Pacemaker) is: ENROLLING_BY_INVITATION.

When did Rehabilitation With the Shoulder Pacemaker start?

Rehabilitation With the Shoulder Pacemaker started on 2023-08-02.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.